Parieto-occipital glucose hypometabolism in Parkinson's disease with autonomic failure. (Q48185492)

From Wikidata

Jump to navigation Jump to search

scientific article published in March 1999

Parieto-occipital glucose hypometabolism in Parkinson’s disease with autonomic failure

Language	Label	Description	Also known as
English	Parieto-occipital glucose hypometabolism in Parkinson's disease with autonomic failure.	scientific article published in March 1999	Parieto-occipital glucose hypometabolism in Parkinson’s disease with autonomic failure

Statements

scholarly article

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/10371072

Parieto-occipital glucose hypometabolism in Parkinson's disease with autonomic failure. (English)

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/10371072

Parkinson's disease

1 reference

based on heuristic

inferred from title

author name string

Arahata Y

1

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/10371072

Hirayama M

2

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/10371072

Ieda T

3

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/10371072

Koike Y

4

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/10371072

Kato T

5

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/10371072

Tadokoro M

6

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/10371072

Ikeda M

7

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/10371072

Ito K

8

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/10371072

Sobue G

9

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/10371072

publication date

1 March 1999

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/10371072

Journal of the Neurological Sciences

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/10371072

163

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/10371072

2

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/10371072

119-126

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/10371072

A clinicopathologic study of 100 cases of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Autonomic dysfunction in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Multiple system atrophy--the nature of the beast

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Alternative approach to single-scan estimation of cerebral glucose metabolic rate using glucose analogs, with particular application to ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Effects of percent thresholding on the extraction of [18F]fluorodeoxyglucose positron emission tomographic region-of-interest data

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Cerebral glucose utilization, as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

The metabolic topography of normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Positron emission tomography of reversible intellectual impairment induced by long-term anticholinergic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Cerebral glucose metabolism in Parkinson's disease with and without dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Regional cerebral glucose metabolism in patients with Parkinson's disease with or without dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Cortical glucose metabolism in Parkinson's disease without dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Antemortem diagnosis of diffuse Lewy body disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Diffuse Lewy body disease in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900011-8

7 January 2021

Identifiers

10.1016/S0022-510X(99)00011-8

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/10371072

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/10371072

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48185492&oldid=2082266247"